Survey of Pharmacist Prescribers working in myeloma clinics

Dear all,

The Research Subcommittee and the UK Myeloma Society (UKMS) pharmacy group would like to invite pharmacists prescribing in myeloma clinics to complete this questionnaire.

There has been a significant increase in the number of new drug approvals in Myeloma with the majority of these continued until progression. A key theme at the BSH (British Society of Haematology) 2023 annual symposium was how to plan the future haematology workforce. We are aiming to understand the extent and nature of pharmacist prescribing within the myeloma setting. The analysis will be shared with the wider haematology community and promote the important role pharmacist prescribers are undertaking in myeloma.

This should take approx. 12 minutes to complete. No login is required, and you should be able to complete using any device. All responses will be anonymised in the final analysis. If you have any questions please email [email protected] or [email protected]

The survey will remain open until 13th August 2023 and can be accessed via the following link or the attached QR Code
https://forms.office.com/e/3qHt0CZgF0

Catherine Loughran, Advanced Pharmacy Practitioner in Haematology
Rachel Senior, Advanced Clinical Pharmacist in Haematology
BOPA Research Subcommittee